Suppr超能文献

阿坎酸的药理学:概述

Pharmacology of acamprosate: an overview.

作者信息

Zornoza Teodoro, Cano María J, Polache Ana, Granero Luis

机构信息

Department of Pharmaceutics, Faculty of Pharmacy, University of Valencia, Spain.

出版信息

CNS Drug Rev. 2003 Winter;9(4):359-74. doi: 10.1111/j.1527-3458.2003.tb00260.x.

Abstract

In the last years important advances have been made in the development of drugs for the treatment of alcohol addiction. Acamprosate (calcium bis-acetylhomotaurine) is one of the better established drugs in this field on the European market. This review focuses first on the pharmacokinetics of acamprosate. The published data and the recent advances in our knowledge on the mechanisms involved in the intestinal absorption and elimination of this drug are summarized. The importance of pharmacokinetics for the proper clinical use of acamprosate is highlighted. The anti-relapse as well as the well-known effects of acamprosate on ethanol intake are discussed. The recent experiments in animal models of conditioned withdrawal are reviewed. These experiments, explored for the first time the anticraving effect of the drug. Finally, the proposed hypotheses on the neuropharmacological mechanism of action of acamprosate are discussed. The discussion deals with the relative importance of various hypotheses as well as with the recent experiments that support them. It is pointed out that further research is necessary in order to clearly understand the mode of action of acamprosate as well as the neurobiological mechanisms involved in alcohol dependence.

摘要

近年来,在用于治疗酒精成瘾的药物研发方面取得了重要进展。阿坎酸(双乙酰高牛磺酸钙)是欧洲市场上这一领域中较成熟的药物之一。本综述首先聚焦于阿坎酸的药代动力学。总结了已发表的数据以及我们在该药物肠道吸收和消除所涉及机制方面知识的最新进展。强调了药代动力学对阿坎酸合理临床应用的重要性。讨论了阿坎酸的抗复发作用以及其对乙醇摄入的众所周知的影响。回顾了近期在条件性戒断动物模型中的实验。这些实验首次探究了该药物的抗渴望作用。最后,讨论了关于阿坎酸神经药理学作用机制的提出的假说。该讨论涉及各种假说的相对重要性以及支持它们的近期实验。指出有必要进行进一步研究,以便清楚地了解阿坎酸的作用方式以及酒精依赖所涉及的神经生物学机制。

相似文献

1
Pharmacology of acamprosate: an overview.
CNS Drug Rev. 2003 Winter;9(4):359-74. doi: 10.1111/j.1527-3458.2003.tb00260.x.
4
Acamprosate: a prototypic neuromodulator in the treatment of alcohol dependence.
CNS Neurol Disord Drug Targets. 2010 Mar;9(1):23-32. doi: 10.2174/187152710790966641.
5
Pharmacological mechanisms of naltrexone and acamprosate in the prevention of relapse in alcohol dependence.
Am J Addict. 2003;12(s1):s3-s11. doi: 10.1111/j.1521-0391.2003.tb00492.x.
6
Acamprosate produces its anti-relapse effects via calcium.
Neuropsychopharmacology. 2014 Mar;39(4):783-91. doi: 10.1038/npp.2013.264. Epub 2013 Sep 30.
7
The clinical pharmacology of acamprosate.
Br J Clin Pharmacol. 2014 Feb;77(2):315-23. doi: 10.1111/bcp.12070.
8
[Acamprosate--new preclinical research aspects].
MMW Fortschr Med. 2003 Oct 9;145 Suppl 3:61-4.
9
The development of acamprosate as a treatment against alcohol relapse.
Expert Opin Drug Discov. 2014 Nov;9(11):1355-69. doi: 10.1517/17460441.2014.960840. Epub 2014 Sep 26.
10
Effect of the combination of naltrexone and acamprosate on alcohol intake in mice.
Psychiatry Clin Neurosci. 2004 Feb;58(1):30-6. doi: 10.1111/j.1440-1819.2004.01189.x.

引用本文的文献

1
The effects of acamprosate on prefrontal cortical function are mimicked by CaCl2 and they are influenced by the history of alcohol exposure.
Neuropharmacology. 2022 Jul 1;212:109062. doi: 10.1016/j.neuropharm.2022.109062. Epub 2022 Apr 14.
3
Prospects for new drugs to treat binge-eating disorder: Insights from psychopathology and neuropharmacology.
J Psychopharmacol. 2022 Jun;36(6):680-703. doi: 10.1177/02698811211032475. Epub 2021 Jul 28.
4
Calcium chloride mimics the effects of acamprosate on cognitive deficits in chronic alcohol-exposed mice.
Psychopharmacology (Berl). 2018 Jul;235(7):2027-2040. doi: 10.1007/s00213-018-4900-1. Epub 2018 Apr 20.
5
Neuroprotective Drug for Nerve Trauma Revealed Using Artificial Intelligence.
Sci Rep. 2018 Jan 30;8(1):1879. doi: 10.1038/s41598-018-19767-3.
6
The development of acamprosate as a treatment against alcohol relapse.
Expert Opin Drug Discov. 2014 Nov;9(11):1355-69. doi: 10.1517/17460441.2014.960840. Epub 2014 Sep 26.
7
Circadian and acamprosate modulation of elevated ethanol drinking in mPer2 clock gene mutant mice.
Chronobiol Int. 2011 Oct;28(8):664-72. doi: 10.3109/07420528.2011.601968.
8
Acamprosate-responsive brain sites for suppression of ethanol intake and preference.
Am J Physiol Regul Integr Comp Physiol. 2011 Oct;301(4):R1032-43. doi: 10.1152/ajpregu.00179.2011. Epub 2011 Jun 22.
9
Acamprosate for alcohol dependence.
Cochrane Database Syst Rev. 2010 Sep 8(9):CD004332. doi: 10.1002/14651858.CD004332.pub2.
10
The Role of Glial Cells in Drug Abuse.
Curr Drug Abuse Rev. 2009;2(1):76-82. doi: 10.2174/1874473710902010076.

本文引用的文献

2
Acamprosate does not induce a conditioned place preference and reveals no state-dependent effects in this paradigm.
Prog Neuropsychopharmacol Biol Psychiatry. 2003 Jun;27(4):653-6. doi: 10.1016/S0278-5846(03)00075-7.
3
Effects of naltrexone alone and in combination with acamprosate on the alcohol deprivation effect in rats.
Neuropsychopharmacology. 2003 Aug;28(8):1463-71. doi: 10.1038/sj.npp.1300175. Epub 2003 Apr 9.
4
Effects of acamprosate on excitatory amino acids during multiple ethanol withdrawal periods.
Alcohol Clin Exp Res. 2003 Mar;27(3):465-70. doi: 10.1097/01.ALC.0000056617.68874.18.
5
Local acamprosate modulates dopamine release in the rat nucleus accumbens through NMDA receptors: an in vivo microdialysis study.
Naunyn Schmiedebergs Arch Pharmacol. 2003 Feb;367(2):119-25. doi: 10.1007/s00210-002-0674-3. Epub 2003 Jan 23.
9
A pharmacokinetic and pharmacodynamic drug interaction study of acamprosate and naltrexone.
Neuropsychopharmacology. 2002 Oct;27(4):596-606. doi: 10.1016/S0893-133X(02)00368-8.
10
Acamprosate reduces context-dependent ethanol effects.
Psychopharmacology (Berl). 2002 Oct;164(1):10-8. doi: 10.1007/s00213-002-1186-z. Epub 2002 Aug 8.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验